The Role of the Tumor Molecular Profile (CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of the Intestinal Microbiota for Treatment Efficiency, Toxicity, Survival and Quality of Life in Patients With Metastatic or Unresectable Colorectal Cancer During Irinotecan-based Systemic Treatment

Maastricht University

OTHER

Wageningen University & Research

UNKNOWN

Fontys Hogeschool

UNKNOWN

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

Erasmus Medical Center

OTHER

Catharina Ziekenhuis

UNKNOWN

University of North Carolina (USA)

UNKNOWN

Oncology patientenpanel MUMC

UNKNOWN

Stichting Kanker.nl

UNKNOWN

Van Weel-Bethesda Ziekenhuis

UNKNOWN

VieCuri Medisch Centrum voor Noord-Limburg

UNKNOWN

Gelderse Vallei Hospital

OTHER

Danone Nutricia Research

INDUSTRY

Clinical Trial Center Maastricht B.V.

OTHER

Dutch Colorectal Cancer Group (DCCG)

UNKNOWN

Prospectief Landelijk CRC Cohort (PLCRC)

UNKNOWN

CRC-guideline committee

UNKNOWN

CZ zorgverzekeraar

UNKNOWN

Landelijke Werkgroep Diëtisten Oncologie (LWDO)

UNKNOWN

Rode Kruis Ziekenhuis Beverwijk

UNKNOWN

Maastricht University Medical Center

OTHER